SEC 13F Intelligence

Decheng Capital Management III (Cayman), LLC / NVLSEUR

Decheng Capital Management III (Cayman), LLC’s Alpine Immune Sciences Inc Position

Does Decheng Capital Management III (Cayman), LLC own Alpine Immune Sciences Inc (NVLSEUR)? Yes — 6.71M shares worth $77M (+25.63% of its 13F portfolio) as of Q4 2023.

Position Value
$77M
Q4 2023
Shares
6.71M
% of Portfolio
+25.63%
Quarters Held
5
currently held

Position History NVLSEUR

Reported value by quarter
Q1 ’22: $42MQ1 ’22Q2 ’22: $40MQ2 ’22Q3 ’22: $48MQ3 ’22Q3 ’23: $77MQ3 ’23Q4 ’23: $77MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20236.71M$77M+25.63%
Q3 20236.71M$77M+24.54%
Q3 20226.71M$48M+17.51%
Q2 20224.71M$40M+15.19%
Q1 20224.71M$42M+12.94%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Decheng Capital Management III (Cayman), LLC’s full portfolio or all institutional holders of NVLSEUR.